BD Cytofix??? Fixation Buffer and 1 more item

BD Biosciences Pharmingen has been awarded contract A207_PO-0455580 by the University of Virginia, effective July 18, 2026. The contract encompasses the delivery of specialized laboratory reagents and supplies to support research and diagnostic applications. The primary products procured under this agreement include BD Cytofix Fixation Buffer and BD Horizon RB780 Rat Anti-Mouse Ly-76 (TER-119) antibody, both specified as unit purchases.

The contract represents a procurement of biological sciences products by an institution of higher education in Virginia. Specific contract value information, cumulative amounts, and the complete performance period are not detailed in the available documentation. The line items indicate unit pricing structures with quantities to be delivered to the University of Virginia as the buyer. These products are consistent with flow cytometry and immunological research applications commonly conducted in academic research environments.